background
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
coronaviru
involv
sever
acut
respiratori
distress
syndrom
ard
rapid
renal
failur
hospit
outbreak
nosocomi
transmiss
report
howev
sever
issu
remain
viral
excret
cours
object
describ
kinet
pattern
viral
excret
two
infect
patient
studi
design
initi
diagnosi
blood
urin
rectal
respiratori
sampl
collect
regularli
aliquot
store
c
realtim
revers
transcriptas
polymeras
chain
reaction
assay
target
upe
region
merscov
genom
result
patient
die
refractori
ard
renal
failur
merscov
rna
detect
pharyng
tracheal
swab
well
blood
sampl
urin
sampl
day
rectal
swab
neg
patient
also
develop
multipleorgan
failur
surviv
persist
renal
insuffici
creatinin
clearanc
mlmin
persist
interstiti
syndrom
albeit
wean
mechan
ventil
longer
requir
oxygen
tracheal
aspir
posit
day
nasopharyng
swab
neg
biolog
sampl
neg
discuss
lower
respiratori
tract
excret
merscov
could
observ
one
month
sever
ill
patient
present
express
viru
blood
urin
consist
interferon
mediat
immunolog
respons
impair
patient
develop
patient
result
suggest
infect
control
precaut
must
adequ
evalu
clinic
ward
laboratori
expos
merscov
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
viru
appear
arabian
peninsula
june
merscov
belong
order
nidoviral
famili
coronavirida
genu
betacoronaviru
coronavirus
larg
envelop
singlestrand
rna
virus
infect
bird
mammal
sinc
human
coronavirus
known
caus
common
cold
found
caus
bronchiol
pneumonia
mainli
sar
epidem
sarscov
although
asymptomat
infect
report
merscov
caus
sever
pneumonia
acut
respiratori
distress
multipleorgan
failur
lead
high
mortal
rate
recent
publish
analysi
show
patient
sever
diseas
least
one
underli
http
elsevi
bv
right
reserv
condit
includ
diabet
hypertens
chronic
cardiac
diseas
chronic
renal
diseas
studi
also
show
communityacquir
health
care
associ
merscov
infect
occur
patient
chronic
comorbid
condit
june
laboratoryconfirm
case
human
infect
merscov
report
world
health
organ
includ
least
death
sever
case
describ
countri
arabian
peninsula
patient
histori
travel
middl
east
except
secondari
case
describ
uk
franc
merscov
diagnosi
base
viral
rna
detect
sampl
collect
lower
respiratori
tract
tracheal
swab
induc
sputum
endotrach
aspir
bronchoscop
aspir
bronchoalveolar
lavag
sampl
avoid
contamin
upper
respiratori
tract
flora
futhermor
detect
viral
rna
sampl
upper
respiratori
tract
nasal
throat
swab
nasopharyng
aspir
may
remain
neg
lower
respiratori
tract
sampl
posit
date
studi
report
detect
merscov
rna
blood
urin
stool
sampl
howev
mani
question
remain
unsolv
recent
underlin
addit
data
need
document
natur
histori
infect
excret
pattern
viral
kinet
infect
best
sampl
optim
revers
transcriptasepolymeras
chain
reaction
rtpcr
yield
report
full
descript
merscov
rna
detect
data
obtain
sampl
collect
two
infect
patient
admit
french
hospit
may
merscov
rna
detect
use
rtpcr
assay
upper
respiratori
tract
sampl
nasal
swab
lower
respiratori
tract
sampl
induc
sputum
endotrach
aspir
bronchoscop
sampl
bronchoalveolar
lavag
whole
blood
urin
sampl
studi
design
describ
kinet
viral
excret
merscov
infect
analyz
potenti
correl
either
clinic
andor
immunolog
pattern
sampl
collect
accord
isar
protocol
recommend
initi
diagnosi
confirm
rtpcr
perform
lower
respiratori
tract
whole
blood
urin
sampl
follow
diagnosi
sampl
site
regularli
collect
well
rectal
nasal
pharyng
swab
sampl
aliquot
store
c
nucleic
acid
extract
specimen
perform
use
nucleospin
dx
viru
nucleospin
rna
blood
mini
kit
machereynagel
gmbh
co
kg
franc
accord
manufactur
instruct
respiratori
tract
aspir
pretreat
proteinas
k
mgml
min
c
digesteur
eurobio
courtaboeuf
franc
appli
reduc
viscos
sigma
viral
rna
ng
per
assay
sigmaaldrich
chemi
sarl
lisl
dabeau
franc
includ
control
extract
procedur
absenc
inhibitor
extract
rna
test
realtim
rtpcr
assay
target
upe
region
merscov
genom
previous
describ
lightcycl
realtim
pcr
system
roch
courtaboeuf
franc
sampl
qualiti
assess
realtim
rtpcr
target
gapdh
housekeep
gene
posit
control
upe
realtim
rtpcr
vitro
transcrib
rna
combin
sequenc
gene
nucleotid
nucleotid
upe
gene
full
clinic
overview
patient
previous
publish
briefli
patient
man
undergon
renal
transplant
renal
failur
secondari
diabet
regular
medic
includ
mycophenol
mofetil
ciclosporin
prednison
clinic
symptom
began
april
upon
return
travel
transfer
lill
univers
teach
hospit
intens
care
unit
icu
intub
april
may
patient
requir
extracorpor
membran
oxygen
ecmo
support
die
may
refractori
multipl
organ
failur
patient
man
admit
april
medic
histori
includ
histamineinduc
angioedema
treat
system
corticosteroid
therapi
share
patient
room
april
april
may
present
asthenia
myalgia
cough
may
intub
transfer
lill
univers
teach
hospit
icu
patient
requir
ecmo
support
may
refractori
hypoxemia
despit
optim
treatment
patient
success
wean
ecmo
june
juli
percutan
tracheotomi
perform
requir
day
intermitt
haemodialysi
per
week
midjuli
previous
describ
patient
merscov
rna
detect
first
time
bronchoalveolar
lavag
sampl
two
day
onset
symptom
afterward
day
onset
ill
merscov
rna
detect
pharyng
tracheal
swab
obtain
period
merscov
rna
detect
nasal
swab
merscov
rna
detect
also
test
urin
blood
sampl
rectal
swab
viral
rna
detect
blood
sampl
day
onset
ill
urin
sampl
collect
day
onset
ill
merscov
rna
alway
detect
detect
merscov
rna
rectal
swab
alway
remain
neg
result
summar
tabl
correspond
cycl
point
upe
patient
merscov
diagnosi
confirm
detect
viral
rna
induc
sputum
sampl
collect
day
onset
ill
follow
day
merscov
rna
posit
endotrach
aspir
collect
day
onset
ill
day
onset
ill
viral
rna
longer
tracheal
swab
detect
merscov
rna
biolog
sampl
test
neg
throughout
cours
infect
result
summar
tabl
report
describ
timecours
merscov
rna
detect
rtpcr
differ
biolog
sampl
collect
two
patient
differ
outcom
case
viral
rna
detect
endotrach
aspir
day
onset
ill
one
patient
data
confirm
previou
studi
show
detect
viral
rna
oronas
swab
neg
even
though
merscov
rna
detect
tracheobronchi
aspir
throughout
cours
infect
case
fatal
outcom
previous
report
sampl
collect
lower
respiratori
tract
relev
diagnosi
merscov
infect
show
sampl
also
relev
followup
merscov
infect
sinc
respiratori
viral
excret
sustain
one
month
onset
infect
standard
contact
airborn
precaut
must
remain
unchang
appli
correctli
avoid
nosocomi
transmiss
still
possibl
describ
sever
countri
includ
transmiss
healthcar
profession
howev
question
mer
viru
viabil
differ
sampl
henc
infect
sampl
remain
unansw
comparison
respiratori
virus
immunocompet
patient
influenzaviru
rna
detect
detect
day
longterm
detect
coronaviru
rna
shown
previous
sever
immunocompromis
patient
detect
human
coronavirus
rna
stool
sampl
observ
except
sarscov
durat
detect
human
coronavirus
rna
stool
sampl
patient
never
studi
human
coronavirus
rna
never
detect
urin
patient
except
sarscov
rna
lau
et
al
first
patient
viral
rna
detect
whole
blood
day
death
previous
viral
rna
detect
plasma
sampl
blood
cell
pellet
anoth
studi
report
absenc
mersrna
detect
serum
sampl
previou
sarscov
outbreak
viru
rna
detect
plasma
sera
infect
patient
acut
phase
infect
thu
sarscov
merscov
circul
whole
blood
studi
need
determin
merscov
simpli
excret
serum
plasma
infect
white
blood
cell
studi
detect
merscov
rna
rectal
swab
stool
sampl
seem
relev
sampl
detect
viral
rna
digest
tract
merscov
rna
detect
urin
sampl
collect
patient
patient
detect
viral
rna
urin
sampl
previous
describ
onset
infect
low
quantit
amount
viru
describ
longterm
excret
merscov
urin
sampl
patient
renal
failur
merscov
tropism
human
kidney
cell
could
explain
renal
failur
interestingli
patient
develop
renal
failur
requir
renal
replac
viru
found
urinari
tract
virem
patient
howev
relationship
viru
renal
tropism
physiopatholog
renal
failur
clear
question
independ
renal
viral
replic
andor
activ
urinari
secret
viru
remain
unsolv
note
detect
viral
rna
one
dialys
sampl
neg
difficult
conclud
one
sampl
two
case
merscov
infect
present
report
differ
outcom
differ
merscov
detect
profil
patient
favor
outcom
viral
rna
detect
whole
blood
urin
sampl
suggest
merscov
infect
remain
local
respiratori
tract
patient
die
complic
day
prior
death
viral
rna
detect
pharyng
tracheal
swab
whole
blood
urin
suggest
dissemin
viral
infect
likewis
previou
studi
describ
fatal
outcom
report
merscov
rna
detect
sampl
collect
lower
respiratori
tract
whole
blood
urin
stool
sampl
taken
togeth
observ
suggest
merscov
dissemin
system
previous
describ
sarscov
recent
report
two
patient
exhibit
differ
inflammatori
respons
profil
patient
compar
patient
could
promot
interferon
ifn
exhibit
higher
serum
concentr
combin
hostrespons
data
viral
excret
data
report
could
hypothes
interferon
mediat
respons
trigger
merscov
may
limit
viral
diseas
lung
prevent
system
dissemin
viremia
could
support
rational
propos
ifn
treatment
suggest
experiment
data
data
show
merscov
infect
involv
multipl
organ
support
strict
prolong
applic
standard
contact
airborn
precaut
patient
suspect
confirm
merscov
infect
individu
protect
healthcar
profession
care
process
procedur
likewis
protect
also
recommend
laboratori
worker
process
biolog
sampl
collect
patient
sampl
viral
detect
part
routin
clinic
manag
patient
context
merscov
perform
lill
univers
teach
hospit
therefor
specif
fund
necessari
